Twilight Litaka Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Dec ' 14	Dec ' 13	Mar ' 13	Sep ' 12	Mar ' 12

Sales

6.65

19.27

76.16

250.29

365.33

Operating profit

2.71

-14.47

-24.90

23.97

47.06

Interest

-

0.28

-16.73

24.56

25.16

Gross profit

2.71

-14.75

-7.98

-0.25

24.59

EPS (Rs)

-6.97

-6.84

-4.25

-1.49

6.58

Other income

-

-

0.19

0.34

2.69

Stock adjustment

-

-2.66

0.68

3.54

-1.18

Raw material

0.21

4.46

35.68

117.31

150.20

Power and fuel

-

-

-

-

-

Employee expenses

1.43

0.75

3.14

7.09

9.91

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

2.30

31.18

61.56

98.38

159.33

Provisions made

-

-

-

-

-

Depreciation

1.23

2.19

2.55

2.69

2.61

Taxation

-

-

-

0.75

5.67

Net profit / loss

-17.27

-16.94

-10.54

-3.69

16.31

Extra ordinary item

-18.75

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

12.39

12.39

12.39

12.39

12.39

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

244.65

244.65

244.65

256.83

235.21

Agg.of non promotoholding (%)

98.72

98.72

98.72

95.57

94.91

OPM (%)

40.81

-75.08

-32.70

9.58

12.88

GPM (%)

-

-

-10.45

-.10

6.68

NPM (%)

-

-

-13.80

-1.47

4.43